Fenretinide and its relation to cancer

This publication has 48 references indexed in Scilit:

• N-4-Hydroxyphenylretinamide Enhances Retinoic Acid-Induced Differentiation and Retinoylation of Proteins in the Human Acute Promyelocytic Leukemia Cell Line, NB4, by a Mechanism That May Involve Inhibition of Retinoic Acid Catabolism
  Biochemical and Biophysical Research Communications, 1997
• Combined Effect of Tamoxifen or Interf eron-β and 4-Hydroxyphenylretinamide on the Growth of Breast Cancer Cell Lines
  Tumor Biology, 1997
• Differential Effects of Retinoic Acid and N‐(4‐hydroxyphenyl)retinamide on Head and Neck Squamous Cell Carcinoma Cells
  The Laryngoscope, 1996
• Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells
  Cancer Letters, 1996
• Differential Effects of Retinoic Acid (RA) andN-(4-Hydroxyphenyl)retinamide (4-HPR) on Cell Growth, Induction of Differentiation, and Changes in p34cdc2, Bcl-2, and Actin Expression in the Human Promyelocytic HL-60 Leukemic Cells
  Biochemical and Biophysical Research Communications, 1996
• The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1
  European Journal Of Cancer, 1995
• Growth Inhibition and Induction of Apoptosis by Fenretinide in Small-Cell Lung Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1995
• Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: Implications for chemoprevention
  Journal of Cellular Biochemistry, 1995
• Tolerability of the synthetic retinoid fenretinide® (HPR)
  European Journal of Cancer and Clinical Oncology, 1989
• Effect of retinoids on the induction of colon cancer in F344 rats by N-methyl-N-nitrosourea or by 1,2-dimethyihydrazine
  Carcinogenesis: Integrative Cancer Research, 1981